Case Report: Pelvic abscess formation secondary to the use of commercial hemostatic topical agent in an immunocompromised patient?

Various hemostatic agents are currently available for routine laparoscopic procedures, avoiding thermal lesions due to energy devices and the complexity of intracorporeal sutures, however, evidence of complications in immunocompromised patients is still lacking. We present the case of a severely immunocompromised gynecological patient who underwent a routine laparoscopic cystectomy, where a local hemostatic agent was employed; further complications arose, a second diagnostic laparoscopy revealed a pelvic abscess with severe adhesion formation. All under a complicated clinical setting due to an impaired immune response, whether this abscess was caused due to the hemostatic agent or other patient’s conditions remains to be determined, still, various clinical factors and patient’s response need to be taken into account as the cause of the abscess formation. Case Report Case Report: Pelvic abscess formation secondary to the use of commercial hemostatic topical agent in an immunocompromised patient? Mónica Monzón-Vargas1, Yuliana GómezMeraz2 and Rodrigo Ayala-Yáñez3* 1ABC Medical Center, México City, Mexico 2American College of Obstetrics and Gynecology, Mexico 3American Association of Gynecologic Laparoscopy, Mexico Dates: Received: 07 June 2017; Accepted: 01 July, 2017; Published: 03 July, 2017 *Corresponding author: Rodrigo Ayala-Yáñez, American Association of Gynecologic Laparoscopy, Av. Carlos Graéf Fernández 154-339, Tlaxala Santa Fe, Cuajimalpa, México, Tel: 5255 16647208; E-mail: